The changing face of epidemiology of invasive fungal disease in Europe

Mycoses

Volumn 52, Issue 3, 2009, Pages 197-205

  Lass Flörl, Cornelia ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Aspergillosis; Aspergillus; Candidiasis; Epidemiology; Fungal infections

Indexed keywords

ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; MICAFUNGIN; POSACONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ASPERGILLOSIS; CANDIDA; CANDIDA ALBICANS; CANDIDEMIA; CRITICAL ILLNESS; DIAGNOSTIC ACCURACY; DRUG CHOICE; DRUG EFFICACY; EARLY DIAGNOSIS; EUROPE; FUSARIOSIS; HIGH RISK POPULATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; INVASIVE FUNGAL DISEASE; MORTALITY; MUCORMYCOSIS; MYCOSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; THERAPY DELAY;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; CANDIDA; CANDIDIASIS; EUROPE; HUMANS; MYCOSES;

ASPERGILLUS; CANDIDA; CANDIDA ALBICANS;

EID: 63849233258     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2009.01691.x     Document Type: Review

References (84)

1. Holzheimer RG, Dralle H. Management of mycoses in surgical patients: review of the literature. Eur J Med Res 2002 7 : 200 26.
2. Jorda-Marcos R, varez-Lerma F, Jurado M et al. Risk factors for candidaemia in critically ill patients: a prospective surveillance study. Mycoses 2007 50 : 302 10.
3. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007 20 : 133 63.
4. Mahfouz T, Anaissie E. Prevention of fungal infections in the immunocompromised host. Curr Opin Investig Drugs 2003 4 : 974 90.
5. Dimopoulos G, Piagnerelli M, Berre J, Eddafali B, Salmon I, Vincent J-L. Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother 2003 15 : 71 5.
6. Meersseman W, Lagrou K, Maertens J, Van WE. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007 45 : 205 16.
7. Peres-Bota D, Rodriguez-Villalobos H, Dimopoulos G, Melot C, Vincent JL. Potential risk factors for infection with Candida spp. in critically ill patients. Clin Microbiol Infect 2004 10 : 550 5.
8. Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 2006 27 : 359 66.
9. Koch S, Hohne FM, Tietz HJ. Incidence of systemic mycoses in autopsy material. Mycoses 2004 47 : 40 6.
10. Sanz Alonso MA, Jarque RI, Salavert LM, Peman J. Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes. Clin Microbiol Infect 2006 12 : 2 6.
11. Pagano L, Caira M, Candoni A et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006 91 : 1068 75.
12. Pagano L, Caira M, Nosari A et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study - Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007 45 : 1161 70.
13. Girmenia C, Pizzarelli G, Cristini F et al. Candida guilliermondii fungemia in patients with hematologic malignancies. J Clin Microbiol 2006 44 : 2458 64.
14. Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004 42 : 4419 31.
15. Tortorano AM, Peman J, Bernhardt H et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004 23 : 317 22.
16. O'Brien SN, Blijlevens NMA, Mahfouz TH, Anaissie EJ. Infections in patients with hematological cancer: recent developments. Hematology Am Soc Hematol Educ Program 2003 1 : 438 72.
17. Rubin RH. Fungal infections in the organ transplant recipient. In : Anaissie EJ, McGinnis MR, Pfaller MA (eds Clincial Mycology. Philadelphia : Churchill Livingstone, 2003 : 407 16.
18. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003 3 : 685 702.
19. Vrioni G, Matsiota-Bernard P. Molecular typing of Candida isolates from patients hospitalized in an intensive care unit. J Infect 2001 42 : 50 6.
20. Arendrup MC, Fuursted K, Gahrn-Hansen B et al. Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin Microbiol Infect 2008. doi :.
21. Leleu G, Aegerter P, Guidet B, for Collège des Utilisateurs de Base de Données en Réanimation. Systemic candidiasis in intensive care units: a multicenter, matched-cohort study. J Crit Care 2002 17 : 168 75.
22. Presterl E, Daxbock F, Graninger W, Willinger B. Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria. Clin Microbiol Infect 2007 13 : 1072 6.
23. Agvald-Ohman C, Klingspor L, Hjelmqvist H, Edlund C. Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis 2007 40 : 1 9.
24. Charles PE, Dalle F, Aube H et al. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med 2005 31 : 393 400.
25. Leon C, Ruiz-Santana S, Saavedra P et al. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006 34 : 730 7.
26. Almirante B, Rodriguez D, Park BJ et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005 43 : 1829 35.
27. Borg-von Zepelin M, Kunz L, Ruchel R, Reichard U, Weig M, Gross U. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005. J Antimicrob Chemother 2007 60 : 424 8.
28. Viscoli C, Girmenia C, Marinus A et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999 28 : 1071 9.
29. Messer SA, Jones RN, Fritsche TR. International surveillance of Candida spp., Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol 2006 44 : 1782 7.
30. Lortholary O, Dannaoui E, Raoux D et al. In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing. Antimicrob Agents Chemother 2007 51 : 3378 80.
31. Dannaoui E, Lortholary O, Raoux D et al. Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006. Antimicrob Agents Chemother 2008 52 : 778 81.
32. Viudes A, Peman J, Canton E, Ubeda P, Lopez-Ribot JL, Gobernado M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis 2002 21 : 767 74.
33. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004 170 : 621 5.
34. Fourneret-Vivier A, Lebeau B, Mallaret MR et al. Hospital-wide prospective mandatory surveillance of invasive aspergillosis in a French teaching hospital (2000-2002). J Hosp Infect 2006 62 : 22 8.
35. Lass-Florl C, Griff K, Mayr A et al. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 2005 131 : 201 7.
36. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002 34 : 909 17.
37. Cornillet A, Camus C, Nimubona S et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006 43 : 577 84.
38. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997 175 : 1459 66.
39. Martino R, Subira M, Rovira M et al. Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol 2002 116 : 475 82.
40. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002 100 : 4358 66.
41. Marr KA, Patterson T, Denning D. Aspergillosis: pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 2002 16 : 875 94.
42. Post MJ, Lass-Floerl C, Gastl G, Nachbaur D. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients. Transpl Infect Dis 2007 9 : 189 95.
43. Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J 2007 30 : 782 800.
44. Bulpa PA, Dive AM, Garrino MG et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? Intensive Care Med 2001 27 : 59 67.
45. Pagano L, Caira M, Picardi M et al. Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality - SEIFEM-C Report. Clin Infect Dis 2007 44 : 1524 5.
46. Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006 25 : 215 29.
47. Roden MM, Zaoutis TE, Buchanan WL et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005 41 : 634 53.
48. Kontoyiannis DP, Lionakis MS, Lewis RE et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 2005 191 : 1350 60.
49. Girmenia C, Pagano L, Corvatta L et al. The epidemiology of fusariosis in patients with haematological diseases. Br J Haematol 2000 111 : 272 6.
50. Dignani MC, Kiwan EN, Anaissie EJ. Hyalohyphomycoses. In : Anaissie EJ, McGinnis MR, Pfaller MA (eds Clinical Mycology. Philadelphia : Churchill Livingstone, 2003 : 309 24.
51. Nucci M. Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis 2003 16 : 607 12.
52. Nucci M, Marr KA, Queiroz-Telles F et al. Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004 38 : 1237 42.
53. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997 90 : 999 1008.
54. Meletiadis J, Meis JF, Mouton JW, Rodriquez-Tudela JL, Donnelly JP, Verweij PE. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother 2002 46 : 62 8.
55. Mursch K, Trnovec S, Ratz H et al. Successful treatment of multiple Pseudallescheria boydii brain abscesses and ventriculitis/ependymitis in a 2-year-old child after a near-drowning episode. Childs Nerv Syst 2006 22 : 189 92.
56. Munoz P, Marin M, Tornero P, Martin RP, Rodriguez-Creixems M, Bouza E. Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis 2000 31 : 1499 501.
57. Richardson MD. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 2005 56 : i5 i11.
58. ISHAM Working Group. Fungiscope Global Rare Fungal Infection Registry. 2008. http://www.fungiscope.net.
59. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002 113 : 480 5.
60. Arendrup MC, Fuursted K, Gahrn-Hansen B et al. Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol 2005 43 : 4434 40.
61. Poikonen E, Lyytikainen O, Anttila VJ, Ruutu P. Candidemia in Finland, 1995-1999. Emerg Infect Dis 2003 9 : 985 90.
62. Richet H, Roux P, Des CC, Esnault Y, Andremont A. Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect 2002 8 : 405 12.
63. Martin D, Persat F, Piens MA, Picot S. Candida species distribution in bloodstream cultures in Lyon, France, 1998-2001. Eur J Clin Microbiol Infect Dis 2005 24 : 329 33.
64. Petri MG, Konig J, Moecke HP et al. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Intensive Care Med 1997 23 : 317 25.
65. Voss A, Kluytmans JA, Koeleman JG et al. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals. Eur J Clin Microbiol Infect Dis 1996 15 : 909 12.
66. Voss A, le Noble JLML, Verduyn Lunel FM, Foudraine NA, Meis JFGM. Candidemia in intensive care unit patients: risk factors for mortality. Infection 1997 25 : 8 11.
67. Doczi I, Dosa E, Hajdu E, Nagy E. Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000. J Med Microbiol 2002 51 : 677 81.
68. Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol 2002 40 : 3489 92.
69. Girmenia C, Martino P. Fluconazole and the changing epidemiology of candidemia. Clin Infect Dis 1998 27 : 232 3.
70. Luzzati R, Amalfitano G, Lazzarini L et al. Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis 2000 19 : 602 7.
71. Tortorano AM, Biraghi E, Astolfi A et al. European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J Hosp Infect 2002 51 : 297 304.
72. Sandven P, Bevanger L, Digranes A, Gaustad P, Haukland HH, Steinbakk M. Constant low rate of fungemia in Norway, 1991 to 1996. The Norwegian Yeast Study Group. J Clin Microbiol 1998 36 : 3455 9.
73. Costa-de-Oliveira S, Pina-Vaz C, Mendonca D, Goncalves Rodrigues A. A first Portuguese epidemiological survey of fungaemia in a university hospital. Eur J Clin Microbiol Infect Dis 2008 27 : 365 74.
74. Nolla-Salas J, Sitges-Serra A, Leon-Gil C et al. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Intensive Care Med 1997 23 : 23 30.
75. Alonso-Valle H, Acha O, Garcia-Palomo JD, Farinas-Alvarez C, Fernandez-Mazarrasa C, Farinas MC. Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis 2003 22 : 254 7.
76. Lopez Sastre JB, Coto Cotallo GD, Fernandez CB. Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatol 2003 20 : 153 63.
77. Peman J, Canton E, Gobernado M, & the Spanish Working Group ECMM on Candidaemia. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis 2005 24 : 23 30.
78. Klingspor L, Tornqvist E, Johansson A, Petrini B, Forsum U, Hedin G. A prospective epidemiological survey of candidaemia in Sweden. Scand J Infect Dis 2004 36 : 52 5.
79. Garbino J, Kolarova L, Rohner P, Lew D, Pichna P, Pittet D. Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital. Medicine (Baltimore) 2002 81 : 425 33.
80. Marchetti O, Bille J, Fluckiger U et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 2004 38 : 311 20.
81. Health Protection Agency. Candidaemia reports, England, Wales, and Northern Ireland: 2003. CDR Weekly (Online) 2004 14 : 1 3.
82. Libanore M, Prini E, Mazzetti M et al. Invasive Aspergillosis in Italian AIDS patients. Infection 2002 30 : 341 5.
83. Jantunen E, Salonen J, Juvonen E et al. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients. Eur J Haematol 2004 73 : 174 8.
84. Teisseyre J, Kalicinski P, Markiewicz-Kijewska M et al. Aspergillosis in children after liver transplantation: single center experience. Pediatr Transplant 2007 11 : 868 75.